Herbal Medicine Market Share, Size, Trends, Industry Analysis Report By Category (Herbal Pharmaceuticals, Herbal Functional Foods, Herbal Dietary Supplements, Herbal Beauty Products); By Form (Tablets & Capsules, Powders, Extracts, Syrups, Others); By Source (Leaves, Roots & barks, Fruits, Whole Plants, Others); By Distribution Channel (Hospitals & Retail Pharmacies, E-commerce); By Regions, Segments & Forecast, 2020 - 2026

报告摘要

The global Herbal Medicine Market size was valued at USD 84.5 billion in 2019 and is anticipated to grow at a CAGR of 20.5% during the forecast period. This revenue generation can be accredited to its increasing usage by people across the globe for maintaining and improving their health conditions.

Rising demand for natural medicines along with increasing amount of funding for the development of traditional drugs will induce growth opportunities for the industry over coming few years. Additionally, herbal medications are considered as a type of膳食补充剂which are available in market in different forms including powder, extracts, fresh leaves, dried plants, teas, capsules as well as tablets.

了解有关此报告的更多信息：请求样本页面

Rising number of various types of diseases is anticipated to support the industry growth rate during the projection period. Comparatively low cost of these products and building high value for the customers is primarily supporting the development of the market size. Moreover, awareness of these products among the customers across the globe will further boost the product growth rate over the study period.

返回古代，草药已成为各种疾病的常见治疗来源以及增强健康状况。根据国家生物技术信息中心2015年，世界卫生组织（世卫组织）表示，大约70％至80％的全球人口依赖于草药来治疗。2016年，根据美国植物委员会的说法，在美国的草药补充剂的销售提升了7％以上，因此，对传统药物的增加需求将促进项目增长。

草药市场报告范围

该市场主要是根据类别，形式，来源，分销渠道和地理区域进行分段。

By Category	通过形式	B Y来源	通过分销渠道	按地区
草药药业 草药功能食品 草药膳食补充剂 草药美容产品	平板电脑和胶囊 Powders 提取物 Syrups Others	Leaves 根和吠声 水果 Whole plants Others	Hospitals & Retail Pharmacies E-commerce	北美（美国，加拿大） Europe (France, Germany, UK, Italy) 亚太（日本，中国，印度，泰国） 拉丁美洲（墨西哥，巴西，智利） MEA (UAE, Saudi Arabia, South Africa)

了解有关此报告的更多信息：请求样本页面

类别前景

In 2019, herbal pharmaceuticals accounted for a major market share of the herbal medicine market. Increasing aging population along with rising consumer awareness is expected to escalate the segment size during the forecast period. Moreover, various other factors such as supplier innovations, very few or no side effects, and the introduction of Current Good Manufacturing Practices (CGMP) by the FDA for dietary supplements will further enhance the herbal medicine industry size.

预计草药美容产品部分也有望在预测期内证明强劲的市场增长。整个美容产品需求上升，增加可支配收入，轻松可用性的广泛产品组合是一些受益于整体美容产品细分市场增长的因素，这一趋势也导致草药美容产品的需求增加。

Form Outlook

可以以多种形式处理和消耗植物和草药，从而使得可以制造各种产品。它包括Salves，整个草本植物，摩擦，软膏，essential oils、胶囊、糖浆、茶、平板电脑等。艾尔l these products contain dried form or extract of medicinal herbs.

Herbs and plants extract vary in the solvent used and includes long-term boiled extract, alcoholic extracts, roots, bark, hot water extract, vinegars, acetic acid extracts, and cold infusion of plants. However, there is no standardization and the components of traditional drugs may vary significantly between different manufacturers.

Source Outlook

The traditional drugs are made from flower, leaf, stalk, root, cloves, fruit, etc. For instance, Chamomile (flower) is used in the U.S. as an anxiolytic and sedative for relaxation and anxiety while in Europe it is used to reduce inflammation or swelling and for wound healing. Echinacea (leaf, stalk, root) treats and prevents flu, cold, and infections. Garlic (cloves, root) is used for lowering cholesterol and blood pressure. Milk thistle (fruit) improves liver conditions & high cholesterol, and reduces cancer cells growth. Saint John's wort (flower, leaf) is used as an antidepressant.

Several conventional drugs are mainly made from plants sources such as quinine is originated from cinchona bark, morphine from the opium poppy, digoxin from foxglove, aspirin from willow bark among others. The advancements in plant-based medicines will continue, with the industry participants engaged in the large-scale pharmacologic screening of herbs. This will positively impact the industry growth rate in the near future.

分销渠道前景

Distribution channel of herbal medicines can be mainly bifurcated into two channels namely hospitals & pharmacies and e-commerce channel. E-commerce channel is predicted to pose high growth rate during the forecast period owing to rising awareness, increasing usage of mobile phones connected with internet facilities, ability to reach at small towns & villages. More importantly it is a cost-efficient channel as the number of intermediaries are certainly reduced.

区域前景

基于传统的植物药物吸引了来自全球的大量客户。在中国，这些药物发挥着含有和治疗严重急性呼吸综合征（SARS）的重要作用。此外，根据世卫组织，印度和中国对草药研究进行了大量投资。因此，估计亚太地区估计在2020年至2026年之间产生更高的收入。

2019年，北美举行了相当大的市场份额。As per the National Center for Biotechnology Information 2017, the traditional drugs were primarily utilized for conditions such as stroke (48.7%), arthritis (43%), and cancer (43.1%) across the U.S. Additionally, the U.S. has also invested significantly in research and innovation of traditional drugs. This research to look for novel chemical compounds and promising medicinal herbs will further escalate the industry volume by 2026. However, these researches have to go through several ethical questions, some of which are not seen in other types of drug development.

Rising amount of funds for research in medicinal plants along with increasing preference for the plant-based medications will significantly drive the regional market size. Increasing support from government and rising prevalence of chronic diseases will facilitate the regional market growth during the study timeline.

Competitive Landscape

全球草药市场的一些市场参与者是Arizona天然产品，Dasherb Corp，Venus Pharma GmbH，喜马拉雅全球控股有限公司，Zeinpharma Germany Holdings Ltd.，Zeinpharma GmbH，Schaper＆Brümmer，Hishimo Pharmaceuticals，Blackmores Ltd.，Beovita，Bayer AG，Willmar Schwable India PVT博士。Ltd.，Dabur，Patanjali Ayurved Ltd，以及Arkopharma等。该行业参与者从事产品开发和创新，并扩大其全球足迹。

一些主要的草药市场参与者专注于扩展其占亚太地区高增长率市场的足迹。例如，Blackmores Ltd.于2016年5月获得全球疗法。此外，Arkopharma于2016年11月收购了Distrifa，以加强伊比利亚半岛的业务。此外，2017年12月，喜马拉雅全球控股有限公司推出了名为ORO-T的草药，这是一种改进的癌症患者的漱口产品。